Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether inhaled nitric oxide is an effective
treatment for microcirculatory dysfunction and acute organ system failure in the early stage
of sepsis therapy.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of General Medical Sciences (NIGMS)